Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
7150%
Subscribing Stocktwits Users. Updated Oct 8, 2026
Loading...

Century Therapeutics Stocktwits Subscriber Count

Century Therapeutics (IPSC) has 715 subscribers on Stocktwits, roughly flat (-0.1%) over the past three months.

With 715 subscribers, Century Therapeutics has a smaller Stocktwits following than Amgen (14,998) and Gilead Sciences (77,598).

Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.

How IPSC’s Stocktwits Community Feeds the AI Score

Stocktwits subscriber count is a direct read on the size of the retail investor community tracking IPSC. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Century Therapeutics’s Stocktwits community into the IPSC AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.

For daily discussion volume, see IPSC Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.

Month over Month Stocktwits Subscribers

Sep 2026 702
Aug 2026 706
Jul 2026 713
Jun 2026 711
May 2026 712
Apr 2026 720
Get IPSC alerts in real-time
The moment the stocktwits subscribers trend turns, sentiment flips, or insiders trade.
Try Stock Alerts Free

Century Therapeutics Stocktwits Subscribers: Frequently Asked Questions

Century Therapeutics (IPSC) has 715 subscribers (715) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.

Century Therapeutics's Stocktwits subscriber base has been roughly flat (-0.1%) over the past three months. View the trend chart above for the full history.

Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines IPSC’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.

Century Therapeutics underperforms its industry peers when it comes to Stocktwits Subscribers, ranking dead last.

StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.

Sign up and get more insights on Century Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.